Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gehrig

Showing results (151-160 of 193) with videos related to

Pageof 20
Sort By:
Gynecologic Oncology|October 9, 2009
Sunitinib malate in the treatment of recurrent or persistent uterine leiomyosarcoma: a Gynecologic Oncology Group phase II studyMartee L Hensley, Michael W Sill, Dennis R Scribner, et al.
Oncotarget|April 24, 2026
Retraction: JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancerHaifeng Qiu, Jing Li, Leslie H Clark, et al.
Oncotarget|August 31, 2016
JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancerHaifeng Qiu, Jing Li, Leslie H Clark, et al.
American Journal of Translational Research|November 11, 2016
Glutaminase inhibitor compound 968 inhibits cell proliferation and sensitizes paclitaxel in ovarian cancerLingqin Yuan, Xiugui Sheng, Leslie H Clark, et al.
Gynecologic Oncology|September 9, 2015
A multi-institutional study of outcomes in stage I-III uterine carcinosarcomaElizabeth L Dickson, Rachel Isaksson Vogel, Paola A Gehrig, et al.
Gynecologic Oncology|January 31, 2021
Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendationsChad A Hamilton, Bhavana Pothuri, Rebecca C Arend, et al.
Gynecologic Oncology|January 16, 2021
Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations, part IIChad A Hamilton, Bhavana Pothuri, Rebecca C Arend, et al.
Clinical Genetics|May 27, 2015
DFNB16 is a frequent cause of congenital hearing impairment: implementation of STRC mutation analysis in routine diagnosticsB Vona, M A H Hofrichter, C Neuner, et al.
Journal of Medicinal Chemistry|June 1, 1991
Topographically designed analogues of [D-Pen,D-Pen5]enkephalinV J Hruby, G Toth, C A Gehrig, et al.
American Journal of Translational Research|July 12, 2016
Buformin exhibits anti-proliferative and anti-invasive effects in endometrial cancer cellsJoshua Kilgore, Amanda L Jackson, Leslie H Clark, et al.
Pageof 20

Showing results (151-160 of 193) with videos related to

Sort By:
Pageof 20
Gynecologic Oncology|October 9, 2009
Sunitinib malate in the treatment of recurrent or persistent uterine leiomyosarcoma: a Gynecologic Oncology Group phase II studyMartee L Hensley, Michael W Sill, Dennis R Scribner, et al.
Oncotarget|April 24, 2026
Retraction: JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancerHaifeng Qiu, Jing Li, Leslie H Clark, et al.
Oncotarget|August 31, 2016
JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancerHaifeng Qiu, Jing Li, Leslie H Clark, et al.
American Journal of Translational Research|November 11, 2016
Glutaminase inhibitor compound 968 inhibits cell proliferation and sensitizes paclitaxel in ovarian cancerLingqin Yuan, Xiugui Sheng, Leslie H Clark, et al.
Gynecologic Oncology|September 9, 2015
A multi-institutional study of outcomes in stage I-III uterine carcinosarcomaElizabeth L Dickson, Rachel Isaksson Vogel, Paola A Gehrig, et al.
Gynecologic Oncology|January 31, 2021
Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendationsChad A Hamilton, Bhavana Pothuri, Rebecca C Arend, et al.
Gynecologic Oncology|January 16, 2021
Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations, part IIChad A Hamilton, Bhavana Pothuri, Rebecca C Arend, et al.
Clinical Genetics|May 27, 2015
DFNB16 is a frequent cause of congenital hearing impairment: implementation of STRC mutation analysis in routine diagnosticsB Vona, M A H Hofrichter, C Neuner, et al.
Journal of Medicinal Chemistry|June 1, 1991
Topographically designed analogues of [D-Pen,D-Pen5]enkephalinV J Hruby, G Toth, C A Gehrig, et al.
American Journal of Translational Research|July 12, 2016
Buformin exhibits anti-proliferative and anti-invasive effects in endometrial cancer cellsJoshua Kilgore, Amanda L Jackson, Leslie H Clark, et al.
Pageof 20